Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure.

[1]  E. Braunwald,et al.  Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure. , 1981, American heart journal.

[2]  M. Weinberger,et al.  Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure. , 1981, The American journal of medicine.

[3]  N. Hollenberg,et al.  Relation of the Renin‐Angiotensin-Aldosterone System to Clinical State in Congestive Heart Failure , 1981, Circulation.

[4]  R. Alexander,et al.  Regulation of the Postsynaptic α‐Adrenergic Receptor in Rat Mesenteric Artery: Effects of Chemical Sympathectomy and Epinephrine Treatment 1981 , 1981, Circulation research.

[5]  C. Desch,et al.  Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure. , 1980, The American journal of cardiology.

[6]  E. Neer,et al.  Evidence for uncoupling of the beta receptor-adenylate cyclase complex. , 1980, Circulation research.

[7]  E. Braunwald,et al.  Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. , 1980, Annals of internal medicine.

[8]  N. Hollenberg,et al.  Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. , 1980, The New England journal of medicine.

[9]  N. Hollenberg,et al.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. , 1980, The Journal of clinical investigation.

[10]  M. Blaustein,et al.  The Role of the Sodium Pump in the Control of Vascular Tone in the Rat , 1980, Circulation research.

[11]  F. Magrini,et al.  Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema. , 1980, The American journal of cardiology.

[12]  J. Cohn,et al.  Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. , 1980, The American journal of cardiology.

[13]  J. Parker,et al.  Tolerance to the Circulatory Effects of Oral Isosorbide Dinitrate: Rate of Development and Cross–tolerance to Glyceryl Trinitrate , 1980, Circulation.

[14]  R. Alexander,et al.  Characterization of Postsynaptic Alpha‐Adrenergic Receptors by [8H]‐Dihydroergocryptine Binding in Muscular Arteries from the Rat Mesentery , 1980, Hypertension.

[15]  J. Cohn,et al.  Comparative hemodynamic effects of converting enzyme inhibitor and sodium nitroprusside in severe heart failure. , 1980, The American journal of cardiology.

[16]  E. Braunwald,et al.  Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.

[17]  S. Ayres,et al.  Propranolol decreases sympathetic nervous activity reflected by plasma catecholamines during evolution of myocardial infarction in man. , 1980, The Journal of clinical investigation.

[18]  J. Cohn,et al.  Effect of Hydralazine on Renal Failure in Patients with Congestive Heart Failure , 1980, Circulation.

[19]  L. Johnson,et al.  Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. , 1980, The American journal of medicine.

[20]  R. Gorlin,et al.  Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure. , 1979, The New England journal of medicine.

[21]  J. Cohn,et al.  Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart. , 1979, The American journal of cardiology.

[22]  C. Johnston,et al.  LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION , 1979, The Lancet.

[23]  L. Benet,et al.  Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.

[24]  R. Lefkowitz.  Direct binding studies of adrenergic receptors: biochemical, physiologic, and clinical implications. , 1979, Annals of internal medicine.

[25]  E. Sonnenblick,et al.  Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. , 1979, The American journal of cardiology.

[26]  W. Pettinger,et al.  Effects of Prazosin and Phentolamine on Arterial Pressure, Heart Rate, and Renin Activity: Evidence in the Conscious Rat for the Functional Significance of the Presynaptic α-Receptor , 1979, Journal of cardiovascular pharmacology.

[27]  E. Sonnenblick,et al.  Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. , 1979, The New England journal of medicine.

[28]  K. Catt,et al.  Hormonal regulation of peptide receptors and target cell responses , 1979, Nature.

[29]  R. Zelis,et al.  How much can we expect from vasodilator therapy in congestive heart failure? , 1979, Circulation.

[30]  R. Lefkowitz,et al.  Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. , 1979, Life sciences.

[31]  B. Brundage,et al.  Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. , 1979, The American journal of cardiology.

[32]  G. Nicolosi,et al.  Alpha-adrenergic blocking activity of prazosin. Effect on catecholamine levels and catecholamine synthetic enzymes. , 1979, Biochemical pharmacology.

[33]  R. Gorlin,et al.  Hemodynamic and Clinical Tachyphylaxisc to Prazosin-Mediated Afterload Reductionin Severe Chronic Congestive Heart Failure , 1979, Circulation.

[34]  W. Pettinger,et al.  Drug therapy. Prazosin. , 1979, The New England journal of medicine.

[35]  W. Aronow,et al.  Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.

[36]  J. Cohn,et al.  Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure , 1978, Circulation.

[37]  H. Gavras,et al.  Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade. , 1978, British heart journal.

[38]  M. Packer,et al.  Oral vasodilator therapy for chronic heart failure: a plea for caution. , 1978, The American journal of cardiology.

[39]  J. Goodwin,et al.  Beneficial Effect of Salbutamol on Cardiac Function in Severe Congestive Cardiomyopathy: Effect on Systolic and Diastolic Function of the Left Ventricle , 1978, Circulation.

[40]  J. Wikberg.  Pharmacological classification of adrenergic α receptors in the guinea pig , 1978, Nature.

[41]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[42]  E. Braunwald,et al.  Hemodynamic Effects of Intravenous Sodium Nitroprusside in the Conscious Dog , 1978, Circulation.

[43]  J. Cohn,et al.  Contrasting effect of vasodilators on heart rate and plasma catecholamines in patients with hypertension and heart failure , 1978 .

[44]  W. Pettinger,et al.  A functional basis for classification of α-adrenergic receptors , 1977 .

[45]  R. Miller,et al.  Efficacy of Ambulatory Systemic Vasodilator Therapy with Oral Prazosin in Chronic Refractory Heart Failure: Concomitant Relief of Pulmonary Congestion and Elevation of Pump Output Demonstrated by Improvements in Symptomatology, Exercise Tolerance, Hemodynamics and Echocardiography , 1977, Circulation.

[46]  E. Braunwald.  Vasodilator therapy--a physiologic approach to the treatment of heart failure. , 1977, The New England journal of medicine.

[47]  J. Cohn,et al.  Vasodilator therapy of cardiac failure (second of two parts). , 1977, The New England journal of medicine.

[48]  W. Aronow.  Hemodynamics and Antianginal Effects of High Dose Oral Isosorbide Dinitrate After Chronic Use , 1977, Circulation.

[49]  N. Hollenberg,et al.  Accentuated vascular and endocrine response to SQ 20881 in hypertension. , 1977, The New England journal of medicine.

[50]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[51]  B. Massie,et al.  Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.

[52]  J. Diamond,et al.  Effects of stimulant and relaxant drugs on tension and cyclic nucleotide levels in canine femoral artery. , 1976, Molecular pharmacology.

[53]  F. Smith,et al.  The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. , 1976, The Journal of clinical investigation.

[54]  W. Campbell,et al.  Evidence for a Renal α‐Adrenergic Receptor Inhibiting Renin Release , 1976, Circulation research.

[55]  K. Shine,et al.  Vasodilator Therapy for Chronic Left Ventricular Failure , 1976, Circulation.

[56]  M. Caron,et al.  Regulation of adenylate cyclase coupled beta-adrenergic receptors. , 1976, Recent progress in hormone research.

[57]  S. Z. Langer.  The Role of α- and β-Presynaptic Receptors in the Regulation of Noradrenaline Release Elicited by Nerve Stimulation , 1976 .

[58]  J. Brundin,et al.  Dual Adrenoceptor‐mediated Control of Noradrenaline Secretion from Human Vasoconstrictor Nerves: Facilitation by β‐receptors and Inhibition by α‐receptors , 1975 .

[59]  W. Pettinger,et al.  Altered renin release and propranolol potentiation of vasodilatory drug hypotension. , 1975, The Journal of clinical investigation.

[60]  J. Laragh,et al.  Prior Receptor Occupancy as a Determinant of the Pressor Activity of Infused Angiotensin II in the Rat , 1975, Circulation research.

[61]  J. Cohn,et al.  Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure , 1974, Circulation.

[62]  R. Zelis.  The contribution of local factors to the elevated venous tone of congestive heart failure. , 1974, The Journal of clinical investigation.

[63]  S. Z. Langer,et al.  Presynaptic regulation of catecholamine release. , 1974, Biochemical pharmacology.

[64]  J. Koch-weser.  Vasodilation for Vasospastic Hypertension , 1973 .

[65]  W. Campbell,et al.  Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat , 1973, Circulation research.

[66]  J. Henry,et al.  Impaired Atrial Receptor Responses in Dogs with Heart Failure Due to Tricuspid Insufficiency and Pulmonary Artery Stenosis , 1973, Circulation research.

[67]  P. Needleman,et al.  Mechanism of tolerance development to organic nitrates. , 1973, The Journal of pharmacology and experimental therapeutics.

[68]  Oxon Ma.  Gerald Legh Malins McElligott. , 1972 .

[69]  C. Higgins,et al.  Effects of Experimentally Produced Heart Failure on the Peripheral Vascular Response to Severe Exercise in Conscious Dogs , 1972, Circulation research.

[70]  E. Braunwald,et al.  Alterations in the baroreceptor reflex in conscious dogs with heart failure. , 1972, The Journal of clinical investigation.

[71]  S. Taylor,et al.  Phentolamine for vasodilator treatment of severe heart-failure. , 1971, Lancet.

[72]  B. Waldeck,et al.  Inhibitory effect of propranolol on the vasoconstrictor response to sympathetic nerve stimulation , 1970, The Journal of pharmacy and pharmacology.

[73]  W. Aronow,et al.  Evaluation of Nitroglycerin in Angina in Patients on Isosorbide Dinitrate , 1970, Circulation.

[74]  J. Weil,et al.  Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. , 1970, The New England journal of medicine.

[75]  R. Zelis,et al.  Arterial sodium content in experimental congestive heart failure. , 1970 .

[76]  E. Braunwald,et al.  A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. , 1968, The Journal of clinical investigation.

[77]  Y. Kaneko,et al.  Renin release during acute reduction of arterial pressure in normotensive subjects and patients with renovascular hypertension. , 1967, The Journal of clinical investigation.

[78]  L. Lasagna,et al.  A study of cross‐tolerance to circulatory effects of organic nitrates , 1967, Clinical pharmacology and therapeutics.

[79]  E. Braunwald,et al.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.

[80]  E. Braunwald,et al.  Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. , 1962, The New England journal of medicine.

[81]  D. T. Walz,et al.  ISOPROTERENOL VASOMOTOR REVERSAL BY SYMPATHOMIMETIC AMINES , 1960, The Journal of pharmacology and experimental therapeutics.

[82]  A. M. Schwartz.  The cause, relief and prevention of headaches arising from contact with dynamite. , 1946, The New England journal of medicine.